
Ependymomas account for 3 to 6 percent of all tumors of the central nervous system. The overall five-year survival rate is greater than 80 percent. However, new and innovative treatments are needed to reduce side effects from the cancer and its treatment as well as to help those patients who relapse.
“Our hope with Ependymoma Awareness Day is to increase public recognition of this rare tumor and the need for clinical studies to improve early diagnosis, standardize treatment and improve the health status of those living with this disease,” said Mark Gilbert, M.D., the medical director and principal investigator of CERN.( taken from the CERN website https://cern-foundation.org)
Anything purchased from my Grey Matter Collections I will be donating a portion to my friend to help them battle their's constant fight this cancer and be cancer free.
No comments:
Post a Comment